4/10 · Low-Moderate — ~14% forward EPS CAGR, but a $13.9T-AUM, $155B mega-cap growing off a huge base; private-markets/tech optionality is real but won't multibag
Technicals
Downtrend — $995.73, −17% off 52-wk high, below 50-DMA ($1,039) and 200-DMA ($1,064), RSI 45, −5.6% 12-mo vs SPY +20.6%
Conviction
Moderate — 0 expert voices in KB; call rests on fundamentals, valuation and quant
Position sizing
Satellite-to-core, ~2–4%, scale in on the downtrend
Fee compression + market-beta AUM: revenue and the stock both fall with markets, and passive fees keep grinding lower
One-line thesis. The world's largest asset manager ($13.9T AUM) is quietly re-shaping itself into a private-markets and technology firm via the GIP and HPS acquisitions — trading at a below-market ~18× forward earnings after a 17% pullback, which makes it a reasonable tactical buy for patient capital, tempered by the honest fact that its revenue is a leveraged bet on market levels and no Synthos expert covers the name.
◆ Synthos call — Buy — CoreBLK is attractively priced but a top-tier compounder — own it now and add on dips toward the 50-day (~$896–$996).
Downside Risk (lower = safer)
4/10 · Moderate
Fortress balance sheet (net debt/EBITDA 0.5×) & cheap-ish 18× forward, but beta 1.43 & a 17% drawdown show it trades like a market-beta financial.
Growth Quality
7/10 · High
~14% forward EPS CAGR, 59% gross / 40% EBITDA margin, but ROE only ~12% and much of the growth is acquisition-fed (GIP/HPS), not pure organic.
Exponential Potential
4/10 · Moderate
$13.9T AUM leader with private-markets & tech optionality, but a $155B mega-cap growing mid-teens off a huge base — a compounder, not a multibagger.
◆ Target entry zone$896 – $996accumulate in this band; ideal adds on a dip toward the 200-day average near $896, keeping roughly a 15% margin below our $1,175 base-case fair value⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 11%/yrTo justify today’s $996, earnings would have to compound roughly 11% a year for 10 years (9% discount rate). Analysts forecast ~12%/yr, so the market is pricing in about what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
BlackRock is the biggest money manager on the planet. If you own an iShares ETF in your 401(k), you're already a BlackRock customer. It looks after about $13.9 trillion of other people's money and earns a small fee on all of it. It also sells Aladdin, the software that much of Wall Street uses to track risk.
Is the stock cheap or expensive? Reasonably priced, leaning cheap — you're paying about 18 times next year's expected profit, which is below the overall market. The stock has also fallen about 17% from its high, so you're not buying at the top.
Our verdict is Buy — Tactical: a decent, well-run business at a fair price, but buy it slowly because the stock is currently drifting down, not up.
Here's what our three scores mean in plain terms:
Downside Risk 4/10 (fairly safe). The company barely uses debt and prints steady cash — but its earnings rise and fall with the stock market, and the share price swings more than average (it's a "high-beta" stock).
Growth Quality 7/10 (good, not elite). It grows steadily and is very profitable, but a lot of the recent growth came from buying other firms, not purely from its own engine.
Exponential Potential 4/10 (low-moderate). It's already gigantic, so it can compound nicely but is very unlikely to double quickly.
The one big worry: BlackRock earns fees on assets, so when markets fall, its revenue falls too — and the fees it charges keep slowly shrinking as cheap index funds take over. A bad market year hits it twice.
Important honesty note: none of the outside experts Synthos tracks currently say anything about BlackRock. This call is built entirely on the company's own numbers and its valuation — not on any expert conviction.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = BLK · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$995.73
Market cap$155B
P/E trailing43×
P/E FY26E / FY27E19× / 16×
EV / Sales6.2×
EV / EBITDA15.7×
Gross margin59.1%
Net margin24.3%
Dividend yield2.20%
Beta1.434
52-wk range$923 – $1,203
RSI(14)45
50 / 200-DMA$1,039 / $1,064
12-mo return+-6% (SPY +21%)
Street target$1,306 ($1,140–$1,430)
Analyst grades25 Buy · 8 Hold · 0 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on BLK · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
BlackRock (NYSE: BLK) is the largest asset manager in the world, with ~$13.9 trillion in assets under management (AUM) as of Q1 2026. Founded in 1988 and led by co-founder/CEO Larry Fink, it earns the bulk of its revenue as a small percentage fee on the assets it manages — dominated by its iShares ETF franchise — plus a fast-growing technology business (Aladdin, its risk/portfolio platform) and, increasingly, higher-fee private markets (infrastructure and private credit). Fiscal year ends December 31.
The strategic story of the last 18 months is a deliberate pivot up the fee curve: BlackRock closed Global Infrastructure Partners (GIP) in October 2024 and HPS Investment Partners (private credit) in July 2025. These deals lifted goodwill from ~$15.5B (FY23) to $35.3B (FY25) and are the main reason reported revenue jumped +18.7% to $24.2B in FY25 — the growth is real but partly bought, and share count rose (diluted shares ~151M → ~165M) as stock was issued as consideration.
Revenue mix (FY2025, from FMP segmentation):
By product/type: Investment Advice (base fees) $19.18B (79%) · Investment Performance fees $1.42B · Distribution & shareholder service $1.36B · Service/other $0.28B. (FMP's FY25 file folds the technology-services line into "Investment Advice"; management reports Aladdin/tech separately — it was ~$1.6B in FY24 and growing ~20%+.)
By geography: Americas $15.96B (66%) · Europe $7.17B (30%) · Asia-Pacific $1.09B (4%). Revenue is Americas-concentrated.
2. The expert thesis — no expert coverage
There is no expert coverage of BlackRock in the Synthos knowledge base. total_claims = 0; there are zero net-bullish and zero cautionary voices. Nothing in this note is backed by a tracked expert claim_id, and none is cited because none exists.
That is stated plainly on purpose: the Synthos house standard is that honesty is the product. This verdict is fundamentals- and quant-driven only — built from BlackRock's own filings (FMP), live analyst consensus estimates (labeled as estimates), valuation math, and the technical picture. Where the LLY-style notes lean on a panel of independent voices, this one cannot, and readers should weight it accordingly: the conviction rating is Moderate, not High.
3. Synthos scores & the Bull / Base / Bear cases
Three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Moderate
Balance sheet is a fortress — net-debt/EBITDA 0.50×, current ratio 6.8×, interest coverage 12.5×. Valuation is undemanding (18.6× FY26E, below market). But beta 1.43 and a −17% drawdown show it trades like a leveraged market-beta financial: its own AUM-fee revenue is the market.
Growth Quality
7 · Good
~14% forward EPS CAGR (FY25→FY29E), gross margin ~59%, EBITDA margin ~40%, dividend-and-buyback capital return. Held back from elite: ROE only ~11.5% and ROIC ~7.6% (a lot of capital tied up in acquisition goodwill), and much of recent growth is M&A-fed, not organic.
Exponential Potential
4 · Low-Moderate
Genuine optionality in private markets (GIP/HPS) and Aladdin tech, and 10% LTM organic base-fee growth is respectable. But a $155B cap on $13.9T of already-captured AUM growing mid-teens is a compounder, not a multibagger. A small accelerating name would score 8–9; BLK is decelerating off the M&A bump.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores summarize them.
Estimates roughly hit — FY27E EPS ~$61; a steady mid-teens compounder with a fortress balance sheet earns a modest ~19× re-rate as the GIP/HPS integration proves out.
~$1,175 (+18%)
Bear
Market drawdown compresses AUM and base fees; passive fee erosion accelerates; integration disappoints. FY27E EPS misses to ~$52; multiple de-rates to ~16×.
~$850 (−15%)
Synthos fair value = the base case, ~$1,175 (+18%), with the full $850–$1,450 span as the honest range. Our base sits below the Street's $1,306 consensus — we are deliberately more conservative on the multiple because BLK's earnings are market-beta and we do not have expert conviction to lean on. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). BLK is a large-cap compounder, not an exponential:
Acceleration (2nd derivative) is mixed and partly artificial: reported revenue jumped +18.7% in FY25, but that was GIP + HPS being consolidated, not organic acceleration. Underlying organic base-fee growth ran ~6–10% LTM (per the Q1'26 supplement). Strip out M&A and the organic engine is decelerating toward high-single-digits.
Room to run: BlackRock already manages $13.9T — it is a large slice of the investable world. The TAM that matters now is the shift into private markets (a genuinely larger-fee pool) and Aladdin technology revenue. Real, but at a $155B cap a 3× from here implies a ~$465B asset manager — plausible over many years, not a fast multibagger.
Reinvestment runway: capital-light core (capex only ~1.6% of revenue), so returns flow to dividends and buybacks rather than a compounding reinvestment flywheel.
Exponential Potential: Low-Moderate (4/10). Own BLK for durable ~14% earnings compounding plus a real mix-shift into higher-fee private markets and tech — not for a fast multibagger.
Revenue: FY25 $24.22B, +18.7% (FY24 $20.41B, +14.3% on FY23 $17.86B). The FY25 jump is materially M&A-driven (GIP full year + HPS half year).
Quarterly trajectory: Q1'25 $5.28B → Q2 $5.42B → Q3 $6.51B → Q4 $7.01B → Q1'26 $6.77B. The step-up from Q2 to Q3 2025 reflects HPS consolidating.
Margins: gross 59.1% TTM, EBITDA 39.5% TTM, operating ~29.9%, net 24.3% TTM. Reported operating margin optically dipped in FY25 as acquisition/intangible costs flowed through; on an as-adjusted basis (management's Q1'26 supplement) the business runs a low-40s% operating margin.
Earnings: GAAP net income $5.55B FY25 (vs $6.37B FY24 — down because of acquisition-related and intangible-amortization charges); GAAP diluted EPS $35.42. Q1'26 GAAP EPS $14.06; Q1'26 as-reported EPS actual $12.53 per the earnings calendar. Watch the GAAP-vs-adjusted gap — the acquisition accounting depresses GAAP now.
Cash flow: operating CF ~$3.93B FY25 (depressed by consolidated-fund working-capital swings), FCF ~$3.55B; more normally the business converts a high share of net income to cash. Dividends paid $3.35B, buybacks $1.95B — full capital return.
Balance sheet: total debt $15.0B, cash+ST investments $14.3B, net debt only $3.5B → net-debt/EBITDA 0.50×. Goodwill+intangibles $63.3B (37% of assets) after the acquisitions — the one balance-sheet flag: a lot of the book is acquisition premium.
6. Valuation — priced in or room?
BLK is not expensive — arguably the most attractive feature here. Trailing P/E 24.7×, but on live consensus the forward multiple falls fast: 18.6× FY26E → 16.3× FY27E → 14.0× FY28E → 13.3× FY29E as EPS climbs from $53.61 toward $74.94. EV/EBITDA is 15.7× and P/B is 2.7×. For the largest and arguably highest-quality franchise in asset management, a below-market forward multiple is undemanding.
The catch that keeps this from being an obvious value slam-dunk: the "E" is market-dependent. BLK's fees scale with AUM, so a forward P/E computed off a strong-market estimate flatters the multiple; in a drawdown, both E and the multiple compress together. That is why our base multiple (~19×) is modest and why the verdict is Tactical, not Core. Street targets (context): consensus $1,306, high $1,430, low $1,140 (25 Buy / 8 Hold / 0 Sell; letter rating B+). Our $1,175 base is below consensus — deliberately conservative given zero expert corroboration and the market-beta earnings.
7. Technicals (from the tech block)
Trend: down. $995.73 sits below the 50-DMA ($1,039) and the 200-DMA ($1,064), with the 50 below the 200 — a death-cross posture. MACD −17.5 (negative).
Location:−17.2% off the 52-week high ($1,202.59), only +7.9% off the 52-week low ($922.90) — nearer the bottom of its range, with a −17% max drawdown from peak.
Momentum: RSI(14) 44.7 — neutral-to-weak, neither oversold nor overbought.
Relative strength (the tell): BLK −5.6% 12-mo vs SPY +20.6% and QQQ +30.3%; even the 3-month +4.0% lags SPY +13.7% and QQQ +22.0%. Persistent underperformance of both the market and tech.
Read: technicals do not confirm the fundamental value case — the stock is in a downtrend and lagging badly. This argues for scaling in on weakness rather than buying a full position; a reclaim of the 50-DMA (~$1,039) would be the first technical green light.
8. Moat & competitive position
BlackRock's moat is scale + platform: (1) the largest AUM base in the world drives the lowest-cost ETF operation (iShares), a self-reinforcing flywheel in passive; (2) Aladdin embeds BlackRock's technology into rivals', banks' and insurers' own workflows — a genuine switching-cost software moat that also monetizes competitors; (3) the GIP/HPS build-out adds private-markets origination and higher, stickier fees. The threats are equally structural: relentless fee compression in passive, and the fact that revenue is a leveraged bet on market levels.
Peer set (market cap): the traditional-manager comps trade far smaller and cheaper — T. Rowe Price $25B, Franklin $18B, Invesco $12B, Northern Trust $33B, BNY Mellon $97B. The alternatives peers are where the re-rating optionality lives — Blackstone $96B, KKR $84B, Apollo $68B, Ares $38B, Brookfield AM $73B — and they command premium multiples on their private-markets fee streams. BLK's GIP/HPS pivot is explicitly an attempt to earn some of that alt-manager premium; success would justify the bull case's multiple expansion.
9. Management, capital allocation & guidance
Management: co-founder Larry Fink remains CEO — a rare, deeply aligned, long-tenured founder-operator. The strategy (scale passive + build private markets + monetize Aladdin) is coherent and consistently executed.
Capital allocation: disciplined and shareholder-friendly — FY25 dividends $3.35B + buybacks $1.95B, dividend ~2.2% yield, payout ~56%, all on a 0.5× net-debt/EBITDA balance sheet. The GIP/HPS deals were large and partly stock-funded (diluting share count ~9%), so the bet is that higher-fee assets outrun the dilution — a reasonable but unproven wager to monitor.
Insider activity: the sampled Form 4s (filing date 2026-07-02) are all routine director stock awards (A-Award, price $0), i.e. compensation grants — no discretionary open-market buying or selling signal in the window.
Management's own guidance (the earnings-release track): the SEC 8-K route returned BlackRock's Q1 2026 (April 14, 2026) Earnings Release Supplement, but it is a data/reconciliation deck — AUM ($13.9T), Q1 base fees + securities lending ($5.4B), organic growth percentages and GAAP-to-adjusted reconciliations — it contains no quantified forward revenue or EPS outlook. BlackRock does not issue formal numeric guidance. So management forward guidance was not available in a usable form; nothing forward-looking is summarized here (only the boilerplate forward-looking-statements caveat was present).
10. Catalysts & what to watch
Next earnings: 2026-07-15 (Q2'26; Street EPS $12.56, revenue ~$6.69B). Key lines: net flows / organic base-fee growth and the as-adjusted operating margin.
Private-markets integration: HPS and GIP fee-paying AUM ramp and margin — the crux of the bull re-rate.
Organic flows vs. market beta: are inflows positive independent of market appreciation? That separates skill from the tide.
Fee-rate trajectory: blended base-fee rate — is the mix-shift into private markets offsetting passive fee erosion?
Aladdin/technology revenue growth: the ~20%+ software line the market may still under-appreciate.
Thesis tripwires (what would change the call): two consecutive quarters of net outflows; adjusted operating margin sliding below the high-30s%; the private-markets fee rate failing to lift the blended rate; or a market drawdown that resets the AUM base.
11. Key risks
Market-beta revenue (structural): fees scale with AUM, so a broad market decline cuts revenue, earnings and the multiple simultaneously — beta 1.43 quantifies it. This is the single biggest risk.
Fee compression: the secular grind lower in passive fees is relentless; the private-markets pivot is the offset, and it must work.
Acquisition-integration & goodwill: goodwill+intangibles are 37% of assets; if GIP/HPS underdeliver, impairment and the ~9% dilution both hurt.
Regulatory / political: as the largest steward of capital, BLK faces recurring political friction (ESG backlash, "too big" scrutiny, index-fund voting-power debates).
No expert corroboration: unlike our conviction-track names, nothing here is backed by a tracked expert voice — the call rests entirely on fundamentals and quant, and should be weighted accordingly.
12. Verdict, position sizing & monitoring
Buy — Tactical. BlackRock is a high-quality, fortress-balance-sheet franchise (largest AUM in the world, Aladdin software moat, founder-led) trading at an undemanding ~18× forward earnings after a 17% pullback, with a real mix-shift into higher-fee private markets. That combination clears a tactical buy bar. It is not a Core call for three honest reasons: (1) zero expert coverage in the Synthos KB; (2) earnings are market-beta (beta 1.43), so the valuation flatters in strong markets and punishes in weak ones; and (3) the technicals are in a downtrend, lagging both SPY and QQQ badly.
Sizing: satellite-to-core, ~2–4%, and scale in on the downtrend rather than a single lump — a starter now, adds on a 50-DMA reclaim or a washout toward the 52-week low.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. Logged as a tracked Synthos call as of 2026-07-03 at $995.73.
Single biggest risk: market-beta AUM fees plus secular fee compression — a bad market year hits revenue, EPS and the multiple at once.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — BlackRock has no expert coverage in the Synthos knowledge base, so no claim_ids are cited. This note is fundamentals- and quant-driven; fabricated conviction is structurally impossible (claim-ID reconciliation) and none is asserted.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · KB checked 2026-07-03 (empty). Forward figures are analyst consensus (FMP), labeled as estimates.
Management caveat: BlackRock issues no formal numeric guidance; the SEC 8-K supplement contained no forward outlook, so none is summarized.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").